Skip to main content
Clinical Trials/NCT02108379
NCT02108379CompletedNot Applicable

An Open-label Outpatient In-season Study Assessing Compliance and Usability of Rhinix™ Nasal Filters

University of Aarhus1 site in 1 country1,073 target enrollmentStarted: May 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,073
Locations
1
Primary Endpoint
Week 2 likelihood of continued use of RHINIX after study end.

Study Overview

Brief Summary

This study will investigate usability and compliance related to rhinix nasal filters for the treatment of seasonal allergic rhinitis (hay fever) during the natural grass pollen season in Denmark.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Motivated to try a different treatment approach to seasonal allergic rhinitis (documented by answering the call-out by Astma-Allergi Danmark)
  • •Indicates having seasonal allergic rhinitis to grass via online questionnaire
  • •Informed consent (by email acceptance after having received information on the trial)
  • •Assess to internet and email

Exclusion Criteria

  • •Improper fit of the Rhinix™ device

Arms & Interventions

Rhinix Nasal Filters

Experimental

All included will receive rhinix nasal filters

Intervention: Rhinix Nasal Filters (Device)

Outcomes

Primary Outcomes

Week 2 likelihood of continued use of RHINIX after study end.

Time Frame: 1 assessment at the end of the 2nd week of use.

In week 2: The proportion of subjects that rate that they will definitely or are likely to continue using RHINIX after the study is over given that they have stated that they have tried the device.

Week 1 likelihood of continued use of RHINIX after study end.

Time Frame: 1 assessment at the end of the 1st week of use.

In week 1: The proportion of subjects that rate that they will definitely or are likely to continue using RHINIX after the study is over given that they have stated that they have tried the device.

Secondary Outcomes

  • Week 1: RHINIX Control(One assessment at the end of the 1st week of use)
  • Week 2: RHINIX Control(One assessment at the end of the 2nd week of use.)
  • Week 2 satisfaction with RHINIX(One assessment at the end of the 2nd week)
  • Week 1 Satisfaction with RHINIX(1 assessment at the end of the 1st week)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials